PharmacyCodes



Coccinine en es it fr

Categorie

Coccinine Les marques, Coccinine Analogs

Coccinine Les marques melange

  • No information avaliable

    • Coccinine Formule chimique

    C20H24N2O2

    Coccinine RX lien

    http://www.rxlist.com/cgi/generic/quinidine.htm

    Coccinine FDA fiche

    Coccinine FDA

    Coccinine msds (fiche de securite des materiaux)

    Coccinine Synthese de reference

    Aucune information disponible

    Coccinine Poids moleculaire

    324.417 g/mol

    Coccinine Point de fusion

    174 oC

    Coccinine H2O Solubilite

    140 mg / L

    Coccinine Etat

    Solid

    Coccinine LogP

    2.534

    Coccinine Formes pharmaceutiques

    Solution

    Coccinine Indication

    Pour le traitement de pré-excitation ventriculaire et des arythmies cardiaques

    Coccinine Pharmacologie

    Quinidine, un anticonvulsivant hydantoïne, est utilisé seul ou avec des anticonvulsivants phénobarbital ou d'autres pour gérer les crises tonico-cloniques, convulsions psychomotrices, syndromes de douleur neuropathique diabétique, y compris les neuropathie, induites par les digitaliques arythmies cardiaques, et les arythmies cardiaques associées à intervalle QT prolongation.

    Coccinine Absorption

    Aucune information disponible

    Coccinine Toxicite

    Aucune information disponible

    Coccinine Information pour les patients

    Before prescribing QUINAGLUTE® as prophylaxis against recurrence of atrial fibrillation, the physician should inform the patient of the risks and benefits to be expected. Discussion should include the facts

    • that the goal of therapy will be a reduction (probably not to zero) in the frequency of episodes of atrial fibrillation; and
    • that reduced frequency of fibrillatory episodes may be expected, if achieved, to bring symptomatic benefit; but
    • that no data are available to show that reduced frequency of fibrillatory episodes will reduce the risks of irreversible harm through stroke or death; and in fact
    • that such data as are available suggest that treatment with QUINAGLUTE® is likely to increase the patient's risk of death.

    To confirm whether this is the most current prescribing information available on Quinaglute®, or to obtain the most current prescribing information, please call Berlex Laboratories at 1-888-BERLEX-4 (choose option #4, Product Usage Information).

    Coccinine Organismes affectes

    Les humains et autres mammifères